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Abstract
Introduction: Substance abuse/dependency is one of the most important comorbidity in bipolar patients. 
Therefore, recognizing the patterns of substance use is valuable in treatment and management of patients. 
This study was conducted to determine patterns of substance abuse among bipolar patients who were 
hospitalized in an educational hospital. 
Methods: This was a descriptive-analytical study on existing data of 322 patients with bipolar disorder 
admitted in the psychiatric ward of Imam-Hossein hospital. Types of used substances studied and some 
variables such as gender, types of bipolarity, duration of admission, age of onset of bipolar disorder, 
number of hospitalization and types of prescribed treatments were compared in users and nonusers groups. 
Results: In this study, 84 patients (26.1%) had substance abuse. 40.5% were using opioids, 6% mood-
elevators, 7.1% alcohol, and 46.4% were using multiple substances. 
Conclusion: It can be concluded that substance abuse frequency among patients with bipolar disorder is high. 
Using more than one substance was the most frequent pattern of substance abuse in these patients as well. 
Thus, it is necessary to consider possible comorbidity of bipolar disorder in front of patients with 
substance related disorder.  
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Introduction
Like most of psychiatric disorders, comorbidity is a 
rule rather exception in bipolar disorders as well 
(1,6). These co morbidities include alcohol and 
substance use disorders (7,13), drugs such as 
benzodiazepine abuse (14), panic disorder (15, 16), 
social phobia (16), obsessive-compulsive disorder  
(17,18) and eating disorders (binge eating type)
(19). Patients with bipolar disorder have higher 
probability to get comorbid personality disorders, 
especially emotional type (cluster B) (6,20). Anxious 
(cluster C), and eccentric type (cluster A) follow 
cluster B respectively in frequency (21). Besides 
psychiatric disorders medical diseases are frequently 
co-occurred with bipolar disorders (6). Migraine 
headache (11,22,23), multiple sclerosis (24,26), asthma 
(11,27), obesity (28-30), type II diabetes mellitus (31), 
hypothyroidism (32) and renal failure (33) have been 
addressed in some articles. 
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Among these, substance related disorders have 
special situation because in compare to other 
illness, frequency of substance abuse/dependency is 
higher in bipolar disorder (13). Probably the 
relation between bipolar and substance related 
disorders is more complex than a simple 
comorbidity. Although on a different point of view, 
bipolar disorders are also common among 
substance related patients (34,38), the bilateral 
relation between substance and bipolarity is not 
clear and some possibilities have been proposed: 1)
substance related problem is a complication of 
bipolar disorder 2) bipolar disorder is a result of 
substance usage 3) substance and bipolar disorders 
shared common roots (12,13,39,40). 
Regardless of association type, substances including 
alcohol have negative impacts on bipolar disorder, 
which consist of poorer treatment response and also 
attachment (poor compliance), higher suicide rates, 
more number of episodes, more frequent medical 
problems such as liver diseases (6,9,10,13,39,46). 
Various states of mood may affect the pattern of 
substance use among bipolar patients (39), for 
example patients use alcohol more when they are 
manic and use stimulants such as cocaine more 
when depressed (47,49). Bipolar patients can also 
experience hypomanic episode following opioid 
withdrawal (50,51), which reflects their similar 
sensitivity to antidepressants withdrawal hypomania 
(52). Therefore, the substances used by bipolar patients 
vary from time to time and their effects on longitudinal 
course differ from other illness.  
Recognizing patterns of substance use in bipolar 
patients may have diagnostic values. It means 
observing a certain pattern of substance use in 
patients can increase the possibility of bipolar 
disorders diagnosis.  
In this line we assessed patients with bipolar 
disorder in a psychiatric ward in regard to type of 
current and previous substance usage and its 
association to some variables. 
Methods
It was a descriptive study on existing data of patients 
who admitted in a university general hospital1.
At first psychiatric documents of patients who 
admitted with diagnosis of bipolar disorder (type I, 
type II and any other types of bipolar spectrum) 
collected. Patients divided into two groups 1) who 
have a history or current substance and alcohol 
abuse and dependency according to DSM IV TR 
criteria 2) patients without history of substance and 
alcohol dependency or abuse. Cigarette smoking 
was not considered as a substance dependency.  
Information of each patient’s document was recorded 
in a checklist. Documents, in which needed information 
was not completed, were excluded. 
The check list included the demographic data, type 
of bipolar disorder (I, II or bipolar spectrum), type 
of substance related disorder (dependency or 
abuse), substance category used by each patient (for 
example opioids, stimulants, alcohol and poly 
substance); psychiatric comorbidities written in the 
patients’ documents; type of episode for which 
patient admitted (mania, mixed and depressed); 
positive or negative family history of bipolar, 
psychotic and substance related disorder; age of 
onset and known medical disease. The list finalized 
by reviewing two experts of attending professors.  
Variables of two groups mentioned in checklist analyzed 
by SPSS software version 16. 2and t-test was used for 
categorical and continuous variables respectively. 
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Results
322 documents were assessed in this study, in 84 
(26.1%) of them history of substance use was 
positive and 238 (73.9%) patients don’t have a 
history of substance use (table 1).  
Substance users were predominantly male (82.1), 
and this predominance was opposite in bipolar 
patients that have not positive history of substance 
use disorders (odds ratio: 11.98, 95 % CI: 
6.4079 to 22.4267) (table 2). 
 
Table 1. Frequency of substance use in bipolar 
inpatients  
 Frequency Percent 
User 84 26.1 
Non – User 238 73.9 
Total 322 100.0 
Table 2. Gender distribution in patients with and 
without substance use 
 Gender Total 
Male Female 
User 69 
82.1% 
15 
17.9% 
84 
100.0% 
Non-User 66 
27.7% 
172 
72.3% 
238 
100.0% 
Most patients in both groups have the diagnosis of 
bipolar I disorder, and this difference was 
significant. (p=0.0490)(Table 3). 
 
Table 3. Types of bipolarity in substance users and 
nonusers 
 
Bipolar Type Total 
Type Other  
Group User 70
83.3%
14 84
100.0%
Non-
User
216
90.8%
22 238
100.0%
Total 286
88.8%
36
11.2%
322
100.0%
Types of treatment (pharmacotherapy, ECT alone 
and combination of both) were not different 
between users and non-users in this study 
(p=0.23). Also, the probability of taking ECT 
(alone or in combination with drugs) was not 
significantly different in two groups 
(P=0.1304)(Table  4).  
 
Table 4.Types of treatments in two groups 
 
Treatment Type Total 
Drug  ECT  Both 
Group 
 
User 64 
76.2% 
1
1.2% 
19 
22.6% 
84 
100.0% 
Non-
User 
159 
66.8% 
0
.0% 
79 
33.2% 
238 
100.0% 
Total  223 
69.3% 
1
.3% 
98 
30.4% 
322 
100.0% 
These two groups of bipolar patients were not 
significantly different in regard to some parameters 
recorded in the documents i.e. duration of the last 
hospitalization, number of hospitalization and age 
of onset of bipolar disorder (Table 5). 
 
Table 5. Average of days of last hospitalization, 
number of admition and age of onset of bipolarity 
Non users Users  
25.3±20.7 22±18.2 last hospitalization 
P = 0.2 
3.9±3.54 3.09±2.61 N of  hospitalization 
P =0.06 
23.23±14.54 26.05±12.61 age at the onset  
P = 0.12 
The main result of this study is the pattern of 
substance usage in bipolar patients included here. 
As illustrated in table 6, using more than one 
substance in the course of illness was the most 
frequent pattern followed by opioids, alcohol and 
stimulants respectively. 
 
Table 6. Types of substance abused  
N %
Opiods
Psycho Stimulants 
Alcohol 
(more than one) 
Total
34
5
6
39 
84
40.5
6.0 
7.1 
46.4 
100.0
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Conclusion
The frequency of substance use in bipolar patients 
admitted in psychiatric ward was lower than other 
studies (10,53). The possible explanation is that 
substance usage is under the effects of many 
factors other than bipolarity per se. Cultural and 
socioeconomic state of society can influence the 
substance usage in bipolar people like healthy 
ones. Another reason may be the product of legal 
and cultural prohibitions of some substances in 
Iran. This resultin some patients intentionally 
denies substance use anyway. 
According to the study, bipolar patients with a 
history of substance use were predominantly male 
but the state in the non-users was vice versa. 
Although considering the male gender as a risk 
factor for substance use disorders among bipolar 
patients need other designation for research, it 
should be kept in mind that male patients are in a 
remarkable risk of substance abuse or dependency. 
The most common type of bipolar disorder in our 
research was bipolar I. It was not surprising 
because the population from which the data 
extracted was patients need hospitalization. This 
means that our patients may be a certain 
proportion of bipolar patients and we have 
selection bias in sampling. In spite of higher 
frequencies of type I bipolar in users and nonusers, 
the rate of bipolar I disorder was significantly 
higher in nonuser group. As mentioned previously 
substance using is one of factors that predict 
poorer response to treatments among bipolar 
patients. On the other hand, according to some 
evidence patients with non-type I bipolar disorders 
respond less to medication. Here it is not illogical 
to conclude that poorer response in substance user 
patients may be in part related to different types of 
bipolar disorder.  
The most frequent pattern of substance use among 
bipolar patients in this study was abuse or 
dependency to more than one substance. This 
finding correlates with other studies (54). As 
pointed earlier, various states of bipolar disorder 
(mania, depression) directly influence the type of 
substance use. Therefore, it is predictable that 
patients with bipolar disorder, who experience 
different states, use different substances along the 
course of disorder. One important question is “can 
we infer from the results of this survey that 
patients who use multiple substances are at risk of 
bipolarity?”If yes, each clinician must be aware in 
regard to substance users to preclude bipolarity 
and inappropriate related treatments.  
It is clear that response to this question needs 
another research. In an unpublished study by 
Samimi, et al., patients with substance related 
disorders were screened with some instruments to 
detect bipolar disorders. The results showed that 
bipolar spectrum disorders were highly frequent 
among substance users especially who had history 
of multiple substance abuse. 
In conclusion, by the results of this study 
psychiatrists should be aware of this frequent 
comorbidity (substance use and bipolar disorder) 
because two disorders influence each other and 
suitable treatment for both can break the vicious 
circle of prognostic effect of them. 
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